A detailed history of Guardian Asset Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Guardian Asset Advisors, LLC holds 2,355 shares of NVO stock, worth $246,238. This represents 0.19% of its overall portfolio holdings.

Number of Shares
2,355
Previous 2,405 2.08%
Holding current value
$246,238
Previous $343 Million 18.32%
% of portfolio
0.19%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$119.07 - $145.42 $5,953 - $7,270
-50 Reduced 2.08%
2,355 $280 Million
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $29,450 - $35,258
240 Added 11.09%
2,405 $343 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $221,068 - $294,266
2,165 New
2,165 $278 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guardian Asset Advisors, LLC Portfolio

Follow Guardian Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Asset Advisors, LLC with notifications on news.